Company intelligence / Profile preview

PROTEINA Co., Ltd.

Seoul, Seoul Special City, South Koreaproteina.co.id ↗

Ownership: Private
Development stage: Other

Overview

PROTEINA has developed a proprietary platform that quantitatively measures protein-protein interactions from clinical samples. This approach enables more precise diagnostics and the identification of novel therapeutic targets. The company is preparing to enter Phase 1 human trials for blood cancer through a collaboration with a major global pharmaceutical company based in Chicago. If successful, this would be the first such trial using PPI technology on humans.

Therapeutic areas: Oncology
Modalities: Protein-protein interaction (PPI) analysis and diagnosticsPotentially protein-based therapeutics in partnership programs
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

SPID-engineered GIPR antagonist antibody

Preclinical

Partnerships

Global pharmaceutical companies (notably one based in Chicago); others undisclosed

Beyond the preview

Go deeper on PROTEINA Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PROTEINA Co., Ltd..

Explore the full profile